Clinical and Endocrine Effects of a Microdose GnRH Agonist Flare Regimen Administered to Poor Responders Who Are Undergoing In Vitro Fertilization

This publication has 18 references indexed in Scilit:

• Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol
  Fertility and Sterility, 1997
• Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
  Fertility and Sterility, 1997
• The hormonal flare-up following gonadotrophin-releasing hormone agonist administration is influenced by a progestogen pretreatment
  Human Reproduction, 1996
• Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: Evidence for a second flare
  Journal of Assisted Reproduction and Genetics, 1996
• High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome
  Fertility and Sterility, 1996
• Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders
  Fertility and Sterility, 1996
• Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology
  Fertility and Sterility, 1996
• Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women
  Fertility and Sterility, 1995
• A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization
  Fertility and Sterility, 1992
• High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization
  Journal of Assisted Reproduction and Genetics, 1989